Robert Zeillinger

Lab head / Assoc. Professor

Medical University of Vienna
Country flagAustria

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Zeillinger is an Associate Professor and Lab Head at the Medical University of Vienna, Austria. His research focuses on genetic variants associated with various cancers, including cervical and ovarian cancer, as well as circulating tumor cells in prostate cancer. Recent publications highlight his work on interleukin genetic polymorphisms and their association with cancer risk, as well as novel biomarkers for early cancer detection.

Articles (9)

Year:

2025

Interleukin-8 (IL-8) is involved in the regulation of inflammatory processes and carcinogenesis. Single-nucleotide polymorphisms (SNPs) within the IL-8 gene have been shown to alter the risks of lung, gastric, or hepatocellular carcinomas. To date, only one study examined the role of IL-8 SNPs in ovarian cancer (OC), suggesting an association between two IL-8 SNPs and OC risk. In this study, we investigated four common IL-8 SNPs, rs4073 (−251 A>T), rs2227306 (+781 C>T), rs2227543 (+1633 C>T), and rs1126647 (+2767 A>T), using the restriction fragment length polymorphism (PCR-RFLP) technique. Our study included a cohort of 413 women of Central European descent, consisting of 200 OC patients and 213 healthy controls. The most common (73.5%) histological type was high-grade serous OC (HGSOC), whereas 28/200 (14%) patients had endometriosis-related (clear cell or endometrioid) OC subtypes (EROC). In postmenopausal women, three of the four investigated SNPs, rs4073 (−251 A>T), rs2227306 (+781 C>T), and rs2227543 (+1633 C>T), were associated with OC risk. Furthermore, we are the first to report a significant relationship between the T allele or TT genotype of SNP rs1126647 (+2767 A>T) and the EROC subtype (p = 0.02 in the co-dominant model). The TT homozygotes were found more than twice as often in EROC compared to other OC subtypes (39% vs. 19%, p = 0.015). None of the examined SNPs appeared to influence OC risk in premenopausal women, nor were they associated with the aggressive HGSOC subtype or the stage of disease at the initial diagnosis.

Year:

2024

Year:

2024

Year:

2024

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Nicole Heinzl

Medical University of Vienna

AUSTRIA
View details

Eva Obermayr

Medical University of Vienna

AUSTRIA
View details

Sabine Kasimir-Bauer

University Hospital Essen

GERMANY
View details

Oliver Illini

Medical University of Vienna

AUSTRIA
View details

Eva Welsch

Lecturer / Senior Lecturer

BOKU University

AUSTRIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.